24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Molecular and biochemical basis <strong>of</strong> disease<br />

cessive primary microcephaly). So far four genes have been identified:<br />

MCPH1, encoding Microcephalin; MCPH3, encoding CDK5RAP2;<br />

MCPH5, encoding ASPM, and MCPH6, encoding CENPJ . MCPH5<br />

and MCPH1 are the most common loci based on MCPH heterogeneity<br />

studies in Pakistani and Indian populations . The objective <strong>of</strong> this study<br />

was to investigate prevalence <strong>of</strong> ARMR associated with microcephaly<br />

in Iranian families from northeast & southeast <strong>of</strong> Iran . A total <strong>of</strong> 20 consanguineous<br />

families with two or more affected individuals with ARMR<br />

inheritance pattern have been collected after obtaining consent form .<br />

Clinical examination and exclusion <strong>of</strong> chromosomal abnormalities <strong>of</strong><br />

the families were completed and followed by homozygosity mapping<br />

using STRs (Short Tandem Repeats) markers for six mentioned MCPH<br />

loci . Sequencing was performed for the linked families . Nine out <strong>of</strong><br />

twenty families were linked to four <strong>of</strong> these loci as follows: Five were<br />

linked to MCPH5 (25%), and MCPH1, MCPH2 were linked to one family<br />

each (5%), and two were linked to MCPH6 (10%) . We have been<br />

able to identify four novel mutations in four families <strong>of</strong> the MCPH5 . According<br />

to our findings MCPH5 seems to be the most prevalent loci in<br />

Iranian families with mental retardation and microcephaly . Sequencing<br />

for the other linked families is currently underway .<br />

P05.123<br />

microRNA expression and post-transcriptional target genes<br />

analysis from one pair <strong>of</strong> monozygotic twins discordant for<br />

trisomy 21: understanding phenotypic variability in Ds patients<br />

C. Borel, S. Deutsch, C. Gehrig, M. Gagnebin, S. E. Antonarakis;<br />

Department <strong>of</strong> Genetic Medicine and Development, University <strong>of</strong> Geneva Medical<br />

School, CH, GENEVA, Switzerland.<br />

The understanding <strong>of</strong> the molecular pathogenesis <strong>of</strong> trisomy 21 (T21)<br />

is remarkably poor since it is not clear how the extra copy <strong>of</strong> HSA21<br />

leads to a wide range <strong>of</strong> phenotypes . We investigated a new class<br />

<strong>of</strong> functional sequences: microRNAs (miRNAs), that act primarily as<br />

post-transcriptional repressors <strong>of</strong> target genes through 3’UTR interactions.<br />

We studied microRNA gene variation on primary fibroblasts and<br />

heart tissue from one pair <strong>of</strong> monozygotic twins discordant for T21 .<br />

Expression was assayed using Taqman qRT-PCR on 365 mature miR-<br />

NAs, 4 <strong>of</strong> which are encoded by HSA21 . Most <strong>of</strong> deregulated microR-<br />

NAs are tissue specific. Around 12% (fibroblasts) and 25% (heart) <strong>of</strong><br />

microRNAs show a statistically significant difference between the T21<br />

and normal twin, with an average up-regulation <strong>of</strong> 1 .6fold and downregulation<br />

<strong>of</strong> 0 .6fold . Expression levels revealed that HSA21-miR-155<br />

and HSA21-miR-99a are up-regulated about 2fold in fibroblasts and<br />

heart tissue, respectively . We have also examined transcripts that are<br />

post-transcriptionally deregulated in T21 and potential target genes<br />

<strong>of</strong> those deregulated microRNAs . To do so, we separated RNA molecules<br />

<strong>of</strong> primary fibroblasts from the same pair <strong>of</strong> twin in a sucrose<br />

gradient according to their association with ribosomes . Pools <strong>of</strong> fractions<br />

corresponding to the heavy ribosomal fraction (translated RNA)<br />

and total RNA were hybridized to a gene expression microarray . We<br />

identified 45 and 63 transcripts with a post-transcriptional up-regulation<br />

and downregulation in the T21 twin, respectively . To complete this<br />

study, we are currently looking for predicted miRNA target genes and<br />

correlated miRNA expression with the expression <strong>of</strong> its target genes .<br />

P05.124<br />

Distinctive patterns <strong>of</strong> miRNA expression in human muscular<br />

disorders<br />

I. Eisenberg1,2 , A. Eran1 , H. G. Lidov1 , P. B. Kang1 , I. S. Kohane1 , L. M. Kunkel1,2<br />

;<br />

1 2 Children’s Hospital Boston, Boston, MA, United States, Howard Hughes Medical<br />

Institute, Boston, MA, United States.<br />

The muscular disorders are a heterogeneous group <strong>of</strong> inherited diseases<br />

characterized by muscle wasting and progressive weakness,<br />

resulting in significant morbidity and disability. Although considerable<br />

progress has been made in the understanding <strong>of</strong> these disorders, the<br />

underlying molecular pathways remain poorly understood . In light <strong>of</strong><br />

their involvement in modulating cellular phenotypes we hypothesized<br />

that miRNAs might be involved in the regulation <strong>of</strong> the pathological<br />

pathways leading to muscle dysfunction . We describe a comprehensive<br />

miRNA expression pr<strong>of</strong>ile aiming to identify new elements involved<br />

in the regulatory networks <strong>of</strong> muscle and the signature pattern <strong>of</strong> 185<br />

miRNAs associated with ten common myopathological conditions in<br />

human. While five miRNAs were found to be consistently dysregulated<br />

in all samples analyzed suggesting that these miRNAs are involved in<br />

a common underlying regulatory pathway among all diseases, other<br />

miRNAs were identified to be dysregulated only in one given disease<br />

and not in any <strong>of</strong> the others thus pointing to their involvement in a<br />

unique regulatory mechanism .<br />

The subsequent identification <strong>of</strong> potential target genes and the unraveling<br />

<strong>of</strong> biological signaling pathways involved in this regulatory<br />

level in these disorders, point to an additional dimension <strong>of</strong> regulation<br />

<strong>of</strong> muscle function mediated by miRNAs . Together with the tight post<br />

transcriptional regulation at the mRNA level identified in Duchenne and<br />

Miyoshi myopathy and specific mRNA:miRNA predicted interactions,<br />

some <strong>of</strong> which are directly involved in compensatory secondary response<br />

functions and others in muscle regeneration, these findings<br />

suggest an important role <strong>of</strong> miRNAs in the pathology <strong>of</strong> muscular<br />

dystrophy .<br />

P05.125<br />

multiple sclerosis Disease and mitochondria<br />

M. Houshmand;<br />

NIGEB, Tehran, Islamic Republic <strong>of</strong> Iran.<br />

Multiple Sclerosis (MS) is a multifocal demyelinating central nervous<br />

system disorder . To assess relationship between mtDNA haplogroups<br />

and MS, we have sequenced the mtDNA HVS-I in 54 MS patients and<br />

100 control subjects . In this study, kinetic analysis <strong>of</strong> mitochondrial<br />

respiratory chain complex I enzyme was performed on intact mitochondria<br />

isolated from fresh skeletal muscle in MS patients (n =10)<br />

and control subjects (n =11) . The frequencies <strong>of</strong> the Asian (M, BM)<br />

and <strong>European</strong> (N, J, K) mtDNA haplogroups in five major regions <strong>of</strong><br />

Iran was investigated . Unexpectedly, the frequencies <strong>of</strong> the Asian haplogroups<br />

M and BM were low in Iran (2 .34% for haplogroup M; 17 .6%<br />

for haplogroup BM and 80 .06% for haplogroup N) .<br />

We have found that haplogroups A and K are significantly more abundant<br />

in MS patients (P=0 .042 for haplogroup A and P=0 .0005 for haplogroup<br />

K). Our findings showed that complex I activities were significantly<br />

reduced ( P=0 .007) in patients compared with control . However,<br />

we could not find deletion in mtDNA <strong>of</strong> patients with MS. Our results<br />

revealed that 15 (75%) out <strong>of</strong> 20 MS patients had point mutations .<br />

This study suggested that point mutation occurred in mtDNA might be<br />

involved in pathogenesis <strong>of</strong> MS . Our data suggest that Iranian tribes<br />

probably played a remarkable role in the formation <strong>of</strong> these ethnic<br />

groups . It gives the indication that the haplogroup J may be older than<br />

6000-10000 years, and probably developed in Iran, and then expanded<br />

to different regions in Europe and Northwest Asia .<br />

P05.126<br />

the coexistence <strong>of</strong> an East-Asian mitochondrial anthropological<br />

marker and the c8270t, A8332c, and A8347c mtDNA mutations<br />

in a Hungarian family with dystonia and juvenile stroke<br />

syndrome<br />

A. Gal 1 , K. Pentelenyi 1 , V. Remenyi 1 , B. Csanyi 2 , G. Tomory 2 , I. Rasko 2 , M. J.<br />

Molnar 1,3 ;<br />

1 Department <strong>of</strong> Neurology, Semmelweis University, Center <strong>of</strong> Molecular Neurology,<br />

Budapest, Hungary, 2 Biological Research Center, Szeged, Hungary, 3 Montreal<br />

Neurological Institute, McGill University, Montreal, QC, Canada.<br />

The high variability <strong>of</strong> the mitochondrial genome contributes to the<br />

phenotype <strong>of</strong> the mtDNA-related disorders . MtDNA mutations have<br />

been associated with a variety <strong>of</strong> clinical manifestations . The 9-bp<br />

deletion between mtDNA 8271-8280 was originally thought to be an<br />

anthropological marker for peoples <strong>of</strong> East-Asian origin .<br />

The proband was investigated for marked dystonic features . The clinical<br />

symptoms started after a long lasting episode <strong>of</strong> fever and elevated<br />

serum ammonia and lactate level . His brother had transient hyperkinesis,<br />

right hemiparesis . Their mother had in her childhood a stroke with<br />

aphasia and right hemiparesis . Presently she has moderate truncal<br />

ataxia, hypoacusis and cognitive dysfunction .<br />

The mtDNA analysis <strong>of</strong> the proband found a 9bp deletion “CCCCCTCA”<br />

in the mtDNA at the position nt8271-8280, and one C8270T substitution<br />

between COII and tRNA Lys genes in the non-coding hypervariable<br />

segment, and two SNPs (A8332G and A8347C) in the tRNA Lys gene .<br />

The C8270T SNP is a pathogenic mutation, the A8332G and A8347C<br />

SNPs are not described in the literature . None <strong>of</strong> the three SNP was<br />

found in our 100 control cases . The affected Hungarian family belongs<br />

to an ancient B mitochondrial haplogroup .

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!